ReviR Therapeutics Receives FDA Rare Pediatric Disease Designation for RTX-117 in Charcot-Marie-Tooth Disease Written by PR Newswire Enable JavaScript and cookies to continueRead more http://www.prnasia.com/story/archive/5034106_CN34106_0